Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-046961)

Filing Details

Accession Number:: 0001209191-20-046961
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-17 16:37:21
Reporting Period:: 2020-08-13

Accepted Time:: 2020-08-17 16:37:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1660334	Verrica Pharmaceuticals Inc.	VRCA	Pharmaceutical Preparations (2834)	463137900

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1741964	Ted White	C/O Verrica Pharmaceuticals Inc. 10 North High Street, Suite 200 West Chester PA 19380	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-08-13	10,661	$6.28	17,966	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $6.2493 to $6.4086, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.